Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should long COVID surprise us?
Mutations can affect how viruses behave and how well drugs and vaccines work.
You can still be productive and proactive in a variety of ways.
Handwashing is one of the best ways to protect yourself and your family from getting sick. Learn when and how you should wash your hands.
Immediate risk of transmission to the American public is still low, according to experts.
Although this is a serious public health threat, the CDC says the immediate risk to the American public is low.
We take a closer look at the use of antibiotics, and why they aren’t prescribed for colds.
Research shows that hepatitis C can survive on a surface for up to six weeks.
A new study found previously unknown.
UnitedHealth Group, the nation’s largest insurer, paid $100 million for hepatitis C medications during the first quarter of the year.
Eight weeks of the fixed-dose combination tablet of Sovaldi and ledipasvir can cure over 90 percent of non-cirrhotic people with genotype 1 of...
Gilead Sciencesâ€™ fixed-dose combination pill of Sovaldi and ledipasvir cured 94 percent to 99 percent of those with genotype 1 of hepat...
A fixed-dose combo pill of Sovaldi and ledipasvir is poised to boast a 100 percent success rate in curing hepatitis C among those coinfected w...
Researchers presented findings from clinical trials of hepatitis C therapies at the 2014 Conference on Retroviruses and Opportunistic...
Twelve weeks of Sovaldi, Olysio and ribavirin is more cost effective than 24 weeks of Sovaldi and ribavirin when treating interferon-intoleran...
Sovaldi and GS-5816 cured about 95 percent of treatment-naive people with genotypes 1 through 6 of hepatitis C who did not have cirrhosis in a...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.